GnRH agonists and add-back therapy: is there a perfect combination?
Pickersgill
A
A
Department of Obstetrics and Gynaecology and Reproductive Health Care, Hope Hospital, Salford, Lancashire.
D000328:Adult; D004715:Endometriosis / Q000188:drug therapy; D015914:Estrogen Replacement Therapy; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D017588:Hyperandrogenism / Q000188:drug therapy; D007889:Leiomyoma / Q000188:drug therapy; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D007986:Luteinizing Hormone / Q000097:blood; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000139:chemically induced; D014592:Uterine Hemorrhage / Q000188:drug therapy
D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D007987:Gonadotropin-Releasing Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone